Y Shen, X Peng, H Ji, W Gong, H Zhu… - International Journal of …, 2023 - Elsevier
Dapagliflozin (DAPA) confers significant protection against heart and kidney diseases.
However, whether DAPA can alleviate type 4 cardiorenal syndrome (CRS-4)-related …